Completed PHASE3 INTERVENTIONAL 2-arm NCT00529295

Titrated Oral Compared With Vaginal Misoprostol for Labor Induction at Term

Sponsor: China Medical University Hospital

Interventions misoprostol

Updated 5 times since 2017 Last updated: Sep 13, 2007 Started: Jun 30, 2005 Completion: Mar 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00529295, this PHASE3 trial focuses on Labor Induction and remains completed. Sponsored by China Medical University Hospital, it has been updated 5 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jan 2017 — Jan 2021 [monthly]

Completed PHASE3

First recorded

Jun 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

China Medical University Hospital

Data source: China Medical University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Douliu, Taiwan